HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.

RATIONALE High-density lipoprotein (HDL) is a heterogeneous population of particles. Differences in the capacities of HDL subfractions to remove cellular cholesterol may explain variable correlations between HDL-cholesterol and cardiovascular risk and inform future targets for HDL-related therapies. The ATP binding cassette transporter A1 (ABCA1) facilitates cholesterol efflux to lipid-free apolipoprotein A-I, but the majority of apolipoprotein A-I in the circulation is transported in a lipidated state and ABCA1-dependent efflux to individual HDL subfractions has not been systematically studied. OBJECTIVE Our aims were to determine which HDL particle subfractions are most efficient in mediating cellular cholesterol efflux from foam cell macrophages and to identify the cellular cholesterol transporters involved in this process. METHODS AND RESULTS We used reconstituted HDL particles of defined size and composition, isolated subfractions of human plasma HDL, cell lines stably expressing ABCA1 or ABCG1, and both mouse and human macrophages in which ABCA1 or ABCG1 expression was deleted. We show that ABCA1 is the major mediator of macrophage cholesterol efflux to HDL, demonstrating most marked efficiency with small, dense HDL subfractions (HDL3b and HDL3c). ABCG1 has a lesser role in cholesterol efflux and a negligible role in efflux to HDL3b and HDL3c subfractions. CONCLUSIONS Small, dense HDL subfractions are the most efficient mediators of cholesterol efflux, and ABCA1 mediates cholesterol efflux to small dense HDL and to lipid-free apolipoprotein A-I. HDL-directed therapies should target increasing the concentrations or the cholesterol efflux capacity of small, dense HDL species in vivo.

[1]  P. Barter,et al.  Cardioprotective functions of HDLs1 , 2014, Journal of Lipid Research.

[2]  A. Nègre-Salvayre,et al.  Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids: Relevance to Cellular Cholesterol Efflux, Antioxidative, Antithrombotic, Anti-Inflammatory, and Antiapoptotic Functionalities , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[3]  R. D'Agostino,et al.  High-density lipoproteins: a consensus statement from the National Lipid Association. , 2013, Journal of clinical lipidology.

[4]  A. Leis,et al.  Novel Formulation of a Reconstituted High-Density Lipoprotein (CSL112) Dramatically Enhances ABCA1-Dependent Cholesterol Efflux , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[5]  Robert L Wilensky,et al.  Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. , 2011, The New England journal of medicine.

[6]  L. Curtiss,et al.  Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma , 2010, Nature Structural &Molecular Biology.

[7]  A. Khera,et al.  Future Therapeutic Directions in Reverse Cholesterol Transport , 2010, Current atherosclerosis reports.

[8]  K. Gaus,et al.  Expression and stability of two isoforms of ABCG1 in human vascular cells. , 2010, Atherosclerosis.

[9]  P. Giral,et al.  Stimulation of Cholesterol Efflux by LXR Agonists in Cholesterol-Loaded Human Macrophages Is ABCA1-Dependent but ABCG1-Independent , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[10]  G. Franceschini,et al.  Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1. , 2009, Biochemistry.

[11]  K. Gaus,et al.  Cyclosporin A Decreases Apolipoprotein E Secretion from Human Macrophages via a Protein Phosphatase 2B-dependent and ATP-binding Cassette Transporter A1 (ABCA1)-independent Pathway* , 2009, The Journal of Biological Chemistry.

[12]  Gordon H Guyatt,et al.  Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis , 2009, BMJ : British Medical Journal.

[13]  A. Vaughan,et al.  ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation ** This work was supported by National Institutes of Health Grant RO1HL-55362. Published, JLR Papers in Press, September 5, 2008. , 2009, Journal of Lipid Research.

[14]  A. Vaughan,et al.  Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux* , 2009, Journal of Lipid Research.

[15]  I. Gelissen,et al.  Coexistence of Foam Cells and Hypocholesterolemia in Mice Lacking the ABC Transporters A1 and G1 , 2008, Circulation research.

[16]  P. Barter,et al.  New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease , 2007, Current cardiology reports.

[17]  K. Gaus,et al.  Secretion of Apolipoprotein E From Macrophages Occurs via a Protein Kinase A– and Calcium-Dependent Pathway Along the Microtubule Network , 2007, Circulation research.

[18]  D. Rader,et al.  Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. , 2007, The Journal of clinical investigation.

[19]  Amy B. Ghering,et al.  ABCA1-Induced Cell Surface Binding Sites for ApoA-I , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[20]  P. Barter,et al.  Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E Published, JLR Papers in Press, February 1, 2006. , 2006, Journal of Lipid Research.

[21]  M. Hayden,et al.  Macrophage ATP-Binding Cassette Transporter A1 Overexpression Inhibits Atherosclerotic Lesion Progression in Low-Density Lipoprotein Receptor Knockout Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[22]  E. Tuzcu,et al.  Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano. , 2006, Journal of the American College of Cardiology.

[23]  A. Kontush,et al.  Antiatherogenic small, dense HDL—guardian angel of the arterial wall? , 2006, Nature Clinical Practice Cardiovascular Medicine.

[24]  I. Gelissen,et al.  ABCA1 and ABCG1 Synergize to Mediate Cholesterol Export to ApoA-I , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[25]  J. Heinecke,et al.  ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. , 2005, Physiological reviews.

[26]  A. Vaughan,et al.  ABCG1 Redistributes Cell Cholesterol to Domains Removable by High Density Lipoprotein but Not by Lipid-depleted Apolipoproteins* , 2005, Journal of Biological Chemistry.

[27]  G. Halliday,et al.  Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro. , 2005, Biochemistry.

[28]  Paul T. Tarr,et al.  ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. , 2005, Cell metabolism.

[29]  G. Anantharamaiah,et al.  Influence of ApoA-I Structure on the ABCA1-mediated Efflux of Cellular Lipids* , 2004, Journal of Biological Chemistry.

[30]  A. Tall,et al.  ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Dean,et al.  Apolipoprotein A-I-stimulated Apolipoprotein E Secretion from Human Macrophages Is Independent of Cholesterol Efflux* , 2004, Journal of Biological Chemistry.

[32]  A. Kontush,et al.  Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[33]  M. Reilly,et al.  Overexpression of Apolipoprotein A-I Promotes Reverse Transport of Cholesterol From Macrophages to Feces In Vivo , 2003, Circulation.

[34]  P. Barter,et al.  Apolipoprotein A-II Inhibits High Density Lipoprotein Remodeling and Lipid-poor Apolipoprotein A-I Formation* , 2003, Journal of Biological Chemistry.

[35]  S. Yokoyama,et al.  Effects of Mutations of ABCA1 in the First Extracellular Domain on Subcellular Trafficking and ATP Binding/Hydrolysis* 210 , 2003, The Journal of Biological Chemistry.

[36]  E. Favari,et al.  Cellular cholesterol flux studies: methodological considerations. , 2002, Atherosclerosis.

[37]  W. J. Johnson,et al.  Effects of Enrichment of Fibroblasts with Unesterified Cholesterol on the Efflux of Cellular Lipids to Apolipoprotein A-I* , 2002, The Journal of Biological Chemistry.

[38]  A. Horwitz,et al.  Stably transfected ABCA1 antisense cell line has decreased ABCA1 mRNA and cAMP-induced cholesterol efflux to apolipoprotein AI and HDL. , 2001, Biochimica et biophysica acta.

[39]  R. Dean,et al.  A kinetic model to evaluate cholesterol efflux from THP-1 macrophages to apolipoprotein A-1. , 2001, Biochemistry.

[40]  Y. Marcel,et al.  Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL. , 2001, Journal of lipid research.

[41]  R. Lawn,et al.  ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages* , 2000, The Journal of Biological Chemistry.

[42]  J. Mcneish,et al.  The Correlation of ATP-binding Cassette 1 mRNA Levels with Cholesterol Efflux from Various Cell Lines* , 2000, The Journal of Biological Chemistry.

[43]  M. Krieger,et al.  Binding of High Density Lipoprotein (HDL) and Discoidal Reconstituted HDL to the HDL Receptor Scavenger Receptor Class B Type I* , 2000, Journal of Biological Chemistry.

[44]  K. Rye,et al.  The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. , 2000, Biochemistry.

[45]  C. Gabel,et al.  High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  K. Rye,et al.  Formation of Spherical, Reconstituted High Density Lipoproteins Containing Both Apolipoproteins A-I and A-II Is Mediated by Lecithin:Cholesterol Acyltransferase* , 2000, The Journal of Biological Chemistry.

[47]  H. Brewer,et al.  Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[48]  R. Dean,et al.  Sterol Efflux Is Impaired from Macrophage Foam Cells Selectively Enriched with 7-Ketocholesterol* , 1996, The Journal of Biological Chemistry.

[49]  G. Francis,et al.  Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. , 1995, The Journal of clinical investigation.

[50]  R. Dean,et al.  Apolipoprotein A-I-mediated efflux of sterols from oxidized LDL-loaded macrophages. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[51]  J. Eugui,et al.  Immunoturbidimetry of serum apolipoproteins A-I and B on the Cobas Bio centrifugal analyzer: method validation and reference values. , 1994, Clinical biochemistry.

[52]  P. Barter,et al.  The influence of apolipoproteins on the structure and function of spheroidal, reconstituted high density lipoproteins. , 1994, The Journal of biological chemistry.

[53]  R. Stocker,et al.  Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence. , 1994, Methods in enzymology.

[54]  R. Dean,et al.  A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC. , 1993, Analytical biochemistry.

[55]  R. Krauss,et al.  Production of polyacrylamide gradient gels for the electrophoretic resolution of lipoproteins. , 1992, Journal of lipid research.

[56]  A. Jonas,et al.  Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins. , 1990, The Journal of biological chemistry.

[57]  P. Weisweiler Isolation and quantitation of apolipoproteins A-I and A-II from human high-density lipoproteins by fast-protein liquid chromatography. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[58]  J. C. Osborne Delipidation of plasma lipoproteins. , 1986, Methods in enzymology.

[59]  A. Jonas,et al.  Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. , 1982, The Journal of biological chemistry.

[60]  S. Goldstein,et al.  A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. , 1981, Journal of lipid research.

[61]  M. Takayama,et al.  A new enzymatic method for determination of serum choline-containing phospholipids. , 1977, Clinica chimica acta; international journal of clinical chemistry.